...potentially underestimates [the hospitalization rate] as the study was in a fairly healthy population overall. This is a crucial point. ...bodes well for GSK tomorrow. Based on what occurred today, I would say the panel's endorsement of GSK's vaccine tomorrow is a fait accompli.